# Breastfeeding, Antiretroviral, and Nutrition Study

> **NCT00164736** · PHASE3 · COMPLETED · sponsor: **Centers for Disease Control and Prevention** · enrollment: 2369 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Maternal zidovudine/lamivudine/lopinavir-ritonavir
- **DRUG:** Infant nevirapine
- **DIETARY_SUPPLEMENT:** Maternal protein and calorie supplement

## Key facts

- **NCT ID:** NCT00164736
- **Lead sponsor:** Centers for Disease Control and Prevention
- **Sponsor class:** FED
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-03
- **Primary completion:** 2010-01
- **Final completion:** 2010-01
- **Target enrollment:** 2369 (ACTUAL)
- **Last updated:** 2010-04-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00164736

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00164736, "Breastfeeding, Antiretroviral, and Nutrition Study". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00164736. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
